A prospective study sought to determine the value of geriatric assessment in patients with non-Hodgkin lymphoma, compared with assessment based on chronological age.
This study investigated the effects of patients’ perceptions of their disease status and prognosis on quality of life and psychological distress.
Researchers conducted a secondary analysis of data from the phase 3 LY.12 clinical trial to measure effect of frailty on outcomes for patients with lymphoma.
A retrospective review of data from patients with CLL demonstrated varied adherence to guidelines for ramp up initiation and laboratory monitoring.
A retrospective review demonstrated that higher Adult Comorbidity Evaluation 27 scores are prognostic for poorer outcomes in patients with CML.